Healthcare technology company HIVE, based in Chennai, has launched an artificial intelligence (AI)-powered clinical decision support platform designed to provide healthcare professionals with verified, evidence based clinical insights by integrating patient data, medical literature and established treatment guidelines.

Unlike conventional generative AI chatbots that primarily rely on publicly available internet content, the HIVE platform combines patient health records, clinical reasoning frameworks, peer reviewed medical literature, public health datasets and current clinical practice guidelines to support clinical decision making. The company said the platform aims to improve diagnostic accuracy, reduce information gaps and enhance evidence based patient care.

According to HIVE, the platform has been developed to address one of the major challenges facing healthcare professionals today. Managing the rapidly growing volume of medical information while ensuring that clinical decisions remain accurate, transparent and evidence based. By integrating multiple validated sources of clinical knowledge, the platform seeks to provide contextual recommendations while maintaining physician oversight and decision making authority.

The launch comes amid growing global interest in the use of artificial intelligence in healthcare. According to industry estimates, the global AI in healthcare market is projected to exceed USD 180 billion by 2030, driven by increasing adoption of AI technologies in diagnostics, clinical decision support, drug discovery and healthcare operations. In India, digital health and AI driven healthcare solutions are expected to play an increasingly important role in expanding access to quality care and improving healthcare outcomes.

Healthcare experts note that clinical decision support systems have the potential to improve patient safety, reduce diagnostic errors and support more personalized treatment strategies. However, they emphasize that the effectiveness of such systems depends on the quality, reliability and transparency of the underlying data and algorithms.

The HIVE platform’s emphasis on integrating structured clinical data, evidence-based guidelines and validated medical literature reflects a broader shift toward trustworthy and explainable AI in healthcare. Experts believe that such approaches may help address concerns related to misinformation, algorithmic bias and the use of non verified data sources in clinical settings.

India’s healthcare ecosystem has increasingly embraced digital health technologies through initiatives such as the Ayushman Bharat Digital Mission (ABDM), which has facilitated the creation of over 80 crore Ayushman Bharat Health Accounts (ABHA) and the linkage of more than 100 crore digital health records nationwide. Industry observers believe that AI-powered clinical decision support platforms could complement these digital health initiatives by enabling more data driven and patient centric healthcare delivery.

The launch of HIVE’s AI platform underscores the growing role of artificial intelligence in transforming clinical practice and highlights the increasing focus on developing healthcare technologies that prioritize accuracy, transparency and evidence based medical decision making.